LifeMD, Inc. Common Stock (LFMD) is a publicly traded Healthcare sector company. As of May 21, 2026, LFMD trades at $4.26 with a market cap of $205.06M and a P/E ratio of 17.26. LFMD moved -0.93% today. Year to date, LFMD is +8.95%; over the trailing twelve months it is -59.96%. Its 52-week range spans $2.56 to $15.84. Analyst consensus is strong buy with an average price target of $9.00. Rallies surfaces LFMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
LifeMD Q1 Revenue Hits $50.2M with 88% Margin and 42,000 Subscriber Net Adds: LifeMD generated $50.2M revenue in Q1 2026, matching guidance, with an 88% gross margin up 420bps year-over-year and an adjusted EBITDA loss of $4.5M. The company added 42,000 net telehealth subscribers, exited with $34.5M cash, no debt, and affirmed full-year guidance of $220–230M revenue and $12–17M adjusted EBITDA.
| Metric | Value |
|---|---|
| Price | $4.26 |
| Market Cap | $205.06M |
| P/E Ratio | 17.26 |
| EPS | $0.25 |
| Dividend Yield | 0.00% |
| 52-Week High | $15.84 |
| 52-Week Low | $2.56 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $194.06M |
| Net Income | $15.62M |
| Gross Margin | 85.72% |
5 analysts cover LFMD: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $9.00.